Details for New Drug Application (NDA): 073645
✉ Email this page to a colleague
NDA 073645 describes VIVACTIL, which is a drug marketed by Chartwell Rx and Teva Womens and is included in three NDAs. Additional details are available on the VIVACTIL profile page.
The generic ingredient in VIVACTIL is protriptyline hydrochloride. There are six drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the protriptyline hydrochloride profile page.
The generic ingredient in VIVACTIL is protriptyline hydrochloride. There are six drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the protriptyline hydrochloride profile page.
Summary for 073645
| Tradename: | VIVACTIL |
| Applicant: | Chartwell Rx |
| Ingredient: | protriptyline hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 073645
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
| Approval Date: | Aug 24, 1995 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
